RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AbL Diagnostics - Stock

AbL Diagnostics Revenue 2024

AbL Diagnostics Revenue

8.75 M EUR

Ticker

ABLD.PA

ISIN

FR001400AHX6

WKN

A3DL82

In 2024, AbL Diagnostics's sales reached 8.75 M EUR, a 0% difference from the 0 EUR sales recorded in the previous year.

The AbL Diagnostics Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
20228.7540,25
2021--
2020--
2019--
20180.3462,78
20170.6673,85
20160.5570,16

AbL Diagnostics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into AbL Diagnostics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by AbL Diagnostics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects AbL Diagnostics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of AbL Diagnostics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into AbL Diagnostics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing AbL Diagnostics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on AbL Diagnostics’s growth potential.

AbL Diagnostics Revenue, Profit, and EBIT History

DateAbL Diagnostics RevenueAbL Diagnostics EBITAbL Diagnostics Net Income
20228.75 M undefined-370,850 undefined1.11 M undefined
20210 undefined-102,620 undefined257,870 undefined
20200 undefined-91,160 undefined-89,300 undefined
20190 undefined-69,260 undefined-62,940 undefined
2018343,340 undefined56,600 undefined1.62 M undefined
2017655,830 undefined187,150 undefined-25,100 undefined
2016550,130 undefined160,630 undefined-498,990 undefined

AbL Diagnostics stock margins

The AbL Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of AbL Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for AbL Diagnostics.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the AbL Diagnostics's sales revenue. A higher gross margin percentage indicates that the AbL Diagnostics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the AbL Diagnostics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the AbL Diagnostics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the AbL Diagnostics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the AbL Diagnostics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the AbL Diagnostics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

AbL Diagnostics Margin History

AbL Diagnostics Gross marginAbL Diagnostics Profit marginAbL Diagnostics EBIT marginAbL Diagnostics Profit margin
202240.25 %-4.24 %12.64 %
202140.25 %0 %0 %
202040.25 %0 %0 %
201940.25 %0 %0 %
201862.78 %16.49 %472.51 %
201773.85 %28.54 %-3.83 %
201670.16 %29.2 %-90.7 %

AbL Diagnostics Aktienanalyse

What does AbL Diagnostics do?

AbL Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding AbL Diagnostics's Sales Figures

The sales figures of AbL Diagnostics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing AbL Diagnostics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize AbL Diagnostics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in AbL Diagnostics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about AbL Diagnostics Stock

How much revenue did AbL Diagnostics generate this year?

AbL Diagnostics has achieved a revenue of 8.75 M EUR this year.

How much was the turnover of the company AbL Diagnostics compared to the previous year?

The revenue of AbL Diagnostics has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of AbL Diagnostics?

The revenue of AbL Diagnostics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of AbL Diagnostics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of AbL Diagnostics so important for investors?

The revenue of AbL Diagnostics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does AbL Diagnostics pay?

Over the past 12 months, AbL Diagnostics paid a dividend of 2.31 EUR . This corresponds to a dividend yield of about 77.08 %. For the coming 12 months, AbL Diagnostics is expected to pay a dividend of 0 EUR.

What is the dividend yield of AbL Diagnostics?

The current dividend yield of AbL Diagnostics is 77.08 %.

When does AbL Diagnostics pay dividends?

AbL Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AbL Diagnostics?

AbL Diagnostics paid dividends every year for the past 0 years.

What is the dividend of AbL Diagnostics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is AbL Diagnostics located?

AbL Diagnostics is assigned to the 'Industry' sector.

Wann musste ich die Aktien von AbL Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AbL Diagnostics from 10/5/2020 amounting to 18.5 EUR, you needed to have the stock in your portfolio before the ex-date on 10/1/2020.

When did AbL Diagnostics pay the last dividend?

The last dividend was paid out on 10/5/2020.

What was the dividend of AbL Diagnostics in the year 2023?

In the year 2023, AbL Diagnostics distributed 2.313 EUR as dividends.

In which currency does AbL Diagnostics pay out the dividend?

The dividends of AbL Diagnostics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AbL Diagnostics

Our stock analysis for AbL Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AbL Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.